Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

On July 2, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Regeneron's Lynozyfic ...

More than half of Americans are not planning on getting their updated COVID-19 shot this fall. Nearly six in 10 Americans say ...

Neuralink begins trial in UK to test brain chip implants, which is aimed at helping people with paralysis control devices ...

Neuralink, Elon Musk's brain implant company, is expanding its clinical trials to the UK after its US success. The trials aim ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Justin Gover to ...

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...

Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United ...

The Indian company Syngene plans to take over an existing plant in Bayview and make some of the most cutting-edge drugs, ...